Karen Page

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Lasse Folkersen, Stefan Gustafsson, Qin Wang et al. · Nature Metabolism · 2020 · 740 citations · Full text

Cardiomyopathy, Heart Failure, Cardiovascular Disease +9

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

Brett King, Emma Guttman‐Yassky, Elena Peeva et al. · Journal of the American Academy of Dermatology · 2021 · 184 citations · Full text

Backgroundalopecia Areata, Pharmacology, Clinical Trials +10

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study

Walter Reinisch, Julián Panés, Sunil Khurana et al. · Gut · 2015 · 151 citations

Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers

Emma Guttman‐Yassky, Ana B. Pavel, Aisleen Diaz et al. · Journal of Allergy and Clinical Immunology · 2021 · 91 citations · Full text

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis

Christopher Banfield, Matthew Scaramozza, Weidong Zhang et al. · The Journal of Clinical Pharmacology · 2017 · 90 citations · Full text